Do statins reduce the risk of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary interventions?

Affiliations

Free article

Editorial

Martin A Alpert. J Am Coll Cardiol. 2014 Jan.

Free article

. 2014 Jan;63(1):80-2.

doi: 10.1016/j.jacc.2013.07.097. Epub 2013 Sep 25.

¹ Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, Missouri. Electronic address: alpertm@health.missouri.edu.

No abstract available

Keywords: angiography; contrast medium; diabetes mellitus; kidney; statins.

Comment on

Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Leoncini M, et al. J Am Coll Cardiol. 2014 Jan 7-14;63(1):71-9. doi: 10.1016/j.jacc.2013.04.105. Epub 2013 Sep 26. J Am Coll Cardiol. 2014. PMID: 24076283 Clinical Trial.
Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. Han Y, et al. J Am Coll Cardiol. 2014 Jan 7-14;63(1):62-70. doi: 10.1016/j.jacc.2013.09.017. Epub 2013 Sep 26. J Am Coll Cardiol. 2014. PMID: 24076297 Clinical Trial.